Advanced Search

Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
F 40.8 -0.02% -0.01
GBT closed down 0.02 percent on Monday, April 19, 2021, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 4
*** please verify all earnings dates ***
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical GBT trend table...
Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Narrow Range Bar Range Contraction -0.02%
NR7 Range Contraction -0.02%
20 DMA Resistance Bearish -1.28%
Older End-of-Day Signals for GBT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 17 hours ago
Down 2 % 4 days ago
60 Minute Opening Range Breakdown 4 days ago
10 DMA Resistance 4 days ago
Down 1% 4 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Hemoglobin Blood Angioedema Hereditary Angioedema Sickle Cell Disease Hemoglobins Pulmonary Disorders

Is GBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 14 Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
Apr 14 A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus
Apr 9 Shareholders Are Thrilled That The Global Blood Therapeutics (NASDAQ:GBT) Share Price Increased 101%
Apr 8 Global Blood Therapeutics' Sickle Cell Med Results In Rapid, Durable Improvements In Hemoglobin Levels Throughout 72 Weeks Of Treatment
Apr 8 Global Blood Therapeutics' Oxbryta 'significantly improves' hemoglobin levels, reduces hemolysis
Apr 8 Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients
Apr 4 Global Blood Therapeutics: Can This Biotech Still Disrupt The Sickle Cell Disease Space?
Mar 26 Global Blood (GBT) Down 7.1% Since Last Earnings Report: Can It Rebound?
Mar 18 GBT Appoints Alexis A. Thompson, M.D., M.P.H., to Board of Directors
Mar 16 Global Blood Therapeutics strikes deal with Sanofi for sickle cell disease programs
See more GBT news...

Indicators

Indicator Value
52 Week High 83.69
52 Week Low 36.49
Average Volume 877,386
200-Day Moving Average 52.27
50-Day Moving Average 43.81
20-Day Moving Average 41.27
10-Day Moving Average 41.13
Average True Range 1.93
ADX 14.96
+DI 18.60
-DI 22.01
Chandelier Exit (Long, 3 ATRs ) 39.83
Chandelier Exit (Short, 3 ATRs ) 44.11
Upper Bollinger Band 43.70
Lower Bollinger Band 38.85
Percent B (%b) 0.4
BandWidth 11.76
MACD Line -0.73
MACD Signal Line -0.84
MACD Histogram 0.1111
Fundamentals Value
Market Cap 2.52 Billion
Num Shares 61.8 Million
EPS -3.65
Price-to-Earnings (P/E) Ratio -11.19
Price-to-Sales 32.35
Price-to-Book 6.06
PEG Ratio -0.30
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.81
Resistance 3 (R3) 41.82 41.49 41.64
Resistance 2 (R2) 41.49 41.24 41.49 41.58
Resistance 1 (R1) 41.15 41.08 41.32 41.14 41.53
Pivot Point 40.82 40.82 40.91 40.82 40.82
Support 1 (S1) 40.48 40.57 40.65 40.47 40.07
Support 2 (S2) 40.15 40.41 40.15 40.02
Support 3 (S3) 39.81 40.15 39.96
Support 4 (S4) 39.80